OR WAIT null SECS
May 21, 2015
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 11, 2015
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
April 27, 2015
Catalent’s Zydis technology will be used to develop thermo-stable and cold-chain independent vaccines.
April 03, 2015
GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.
March 26, 2015
FDA has approved another indication for Eylea, a treatment for diabetic retinopathy in patients with diabetic macular edema.
March 25, 2015
Emergent BioSolutions announced FDA approval of Anthrasil, an inhalable treatment that targets Anthrax toxins, as well as a contract with BARDA to develop NuThrax, an anthrax vaccine candidate.
March 24, 2015
The agency provides guidance on determining the need for environmental assessments for gene therapies, vectored vaccines, and viral and microbial products.
March 02, 2015
Scientists and industry experts seek effective preventive therapies to combat global disease.
January 23, 2015
Government and industry efforts to address manufacturing challenges move Ebola vaccine candidates into larger clinical trials.
December 15, 2014
Baxter announced that it had entered into an agreement to sell its Vero cell technology and related assets to Nanotherapeutics.